Related Experiment Video
Updated: Oct 23, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Effect of nicotinamide on drug metabolizing enzymes in the neonatal rat
1Department of Foods and Nutrition, Purdue University, West Lafayette, Indiana 47907.
Abstract:
Sprague-Dawley rats were raised by dams (mother reared, MR) or artificially reared from day 4 to day 11, using chronic intragastric cannulas, and infused with one of four diets: control (AR); or supplemented with nicotinamide-low (LN, 300 mg/l), medium (MN, 750 mg/l), or high (HN, 1500 mg/l). Liver to body weight ratios were higher in all artificially reared groups (AR, LN, MN, HN) compared to MR pups. The amount of recovered hepatic microsomal protein was lower in all artificially reared groups when compared with MR pups. Uridine diphosphoglucuronyl transferase activity with para-nitrophenol as the substrate (UDPGT-PNP) was greater in all of the artificially reared groups compared to the MR group. UDPGT-PNP activity in the HN group was greater than in the AR, LN, or MN groups. Cytochrome P-450 concentration was highest in the MR group, whereas there were no differences among the artificially reared groups. It was concluded that the artificial rearing process stimulated hepatic UDPGT-PNP activity and depressed cytochrome P-450 concentrations, whereas dietary supplementation with nicotinamide during the preweanling period resulted in a further increase in UDPGT-PNP activity.
More Related Videos
07:38A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
06:38In Ovo Feeding of Commercial Broiler Eggs: An Accurate and Reproducible Method to Affect Muscle Development and Growth
Published on: September 20, 2021
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase